Elutia Analyst Price Targets

Wall Street analyst price targets and consensus rating for Elutia (ELUT).

Price Target Range — 7 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingOverweight# Analysts2Avg. Consensus PT$7Upside to Avg. PT+803.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 10, 2025	Lake Street	Frank Takkinen	PT Cut	Buy	$8→$6
May 9, 2025	Lake Street	Frank Takkinen	PT Cut	Buy	$10→$8
Mar 7, 2025	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$8
Nov 15, 2024	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$10
Sep 6, 2024	Cantor Fitzgerald	Ross Osborn	Maintained	Overweight	$10
Aug 8, 2024	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$11→$10
Jun 21, 2024	Lake Street	Frank Takkinen	PT Raise	Buy	$5→$10
Jun 20, 2024	Cantor Fitzgerald	Ross Osborn	PT Raise	Overweight	$5→$11
Jun 18, 2024	Cantor Fitzgerald	Ross Osborn	PT Raise	Overweight	$5→$11
May 10, 2024	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$6→$5
Nov 14, 2023	Cantor Fitzgerald	Ross Osborn	PT Cut	Overweight	$8→$6

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $6

Lake Street analyst Frank Takkinen maintains Elutia (NASDAQ:ELUT) with a Buy and lowers the price target from $8 to $6.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $8

Lake Street analyst Frank Takkinen maintains Elutia (NASDAQ:ELUT) with a Buy and lowers the price target from $10 to $8.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $8 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $10 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

Cantor Fitzgerald analyst Ross Osborn reiterates Elutia (NASDAQ:ELUT) with a Overweight and maintains $10 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10

Cantor Fitzgerald analyst Ross Osborn maintains Elutia (NASDAQ:ELUT) with a Overweight and lowers the price target from $11 to $10.

Benzinga Newsdesk

Elutia Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Elutia Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $6

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $8

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10

People Also Watch

People Also Watch

Elutia Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Elutia Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLake Street Maintains Buy on Elutia, Lowers Price Target to $6

PROLake Street Maintains Buy on Elutia, Lowers Price Target to $8

PROCantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

PROCantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PROCantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PROCantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10

People Also Watch

People Also Watch

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $6

PRO
Lake Street Maintains Buy on Elutia, Lowers Price Target to $8

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $8 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target

PRO
Cantor Fitzgerald Maintains Overweight on Elutia, Lowers Price Target to $10